SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending following reports of potential partnerships and investments from companies like TSMC and Apple, fueling speculation about its comeback in the semiconductor industry. The community is actively discussing the implications of these developments, particularly in light of potential government mandates favoring domestic chip manufacturing. Bullish sentiment is growing as investors anticipate significant gains and a potential return to prominence for Intel.

Cipher Mining, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Mining Inc

Cipher Mining (CIFR) is trending due to the announcement of an upsized convertible bond offering and a related hosting agreement with Fluidstack, backed by Google, leading to significant price volatility. While some investors express concerns about potential dilution, others view the developments as a sign of strong market confidence and a catalyst for growth in mining capacity and high-performance computing. The community is actively debating the long-term implications of the offering and its impact on the stock's trajectory.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

Crowd with Knife ($CAW.X) is trending as the community buzzes about its deflationary tokenomics and organic, cult-like following. Discussions highlight its multichain functionality across Solana, BSC, CRO, and ETH (BASE), facilitated by Layerzero tech. The built-in burn mechanism on each bridge is also a key talking point.

Pupu is a community-driven meme project centered around the character “Pupu the Frog,” who represents lighthearted fun and adventure within the crypto space. The project aims to build a digital ecosystem where holders can engage with the narrative of Pupu through memes, social interactions, and community activities. At its core, the project highlights creativity, entertainment, and community participation as primary utilities, while maintaining a transparent and decentralized structure that evolves through user engagement.

Pupu

$PUPU.X is gaining traction as a potential successor in the meme coin space, drawing comparisons to $PEPE and other Solana-based tokens. Community members are actively monitoring its chart and volume, emphasizing the ease of access through Phantom Wallet. The focus remains on its potential for significant growth within the broader crypto market.

Lithium Americas Corp. engages in the development of the Thacker Pass project. It is focused on advancing Thacker Pass to production it is located in northern Nevada. The company was founded on January 23, 2023 and is headquartered in Vancouver, Canada.

Lithium Americas Corp (NewCo)

Lithium Americas Corp

LAC is trending as reports circulate that the U.S. government may take a stake in the company, tied to its DOE loan, sparking debate about government involvement in for-profit business. The community is discussing the potential for a short squeeze and comparing it to similar situations with MP Materials and Intel, while also considering the impact on lithium supply chains and national security. Some traders are pointing to technical indicators and overnight trading activity, while others express skepticism about the company's fundamentals and potential dilution.

Costco Wholesale Corp. engages in the provision of operation of membership warehouses through wholly owned subsidiaries. It operates through the following geographical segments: United States, Canada, and Other International Operations. The company was founded by James D. Sinegal and Jeffrey H. Brotman in 1983 and is headquartered in Issaquah, WA.

Costco Wholesale Corp

Despite a recent earnings beat, Costco's stock is trending as the community debates whether the valuation is justified, especially with tariffs looming. Community members are closely watching membership fee revenue and same-store sales data for indications of future performance. The stock's high PE ratio is also a key point of discussion, with some suggesting it's overvalued compared to growth prospects.

CarMax, Inc. is a holding company, which engages in the retail of used vehicles and wholesale of vehicle auction operators. It operates through the CarMax Sales Operations and CarMax Auto Finance (CAF) segments. The CarMax Sales Operations segment consists of all aspects of its auto merchandising and service operations. The CAF segment pertains to its finance operation, which offers vehicle financing services to customers buying retail vehicles. The company was founded by Richard L. Sharp and William Austin Ligon in 1993 and is headquartered in Richmond, VA.

Carmax Inc

CarMax ($KMX) is trending due to disappointing Q2 results, including a slump in car sales and increased loan loss provisions, leading to a breach of its 52-week low. Community discussions revolve around whether the stock is oversold and if it presents a buying opportunity, with some comparing it unfavorably to competitors like Carvana ($CVNA). The broader context involves concerns about the used car market, high interest rates, and potential impacts from tariffs.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X Shares

Direxion Daily Semiconductor Bear 3X Shares

SOXS is trending as traders react to potential shifts in the semiconductor landscape, particularly influenced by Intel's recent activity and news regarding potential import restrictions. Community discussions revolve around whether the current semi surge is sustainable, with many pointing to AI hype and government intervention as key factors. Some traders are looking at SOXS as a potential hedge against an overvalued market, while others believe the sector still has room to run.

Crinetics Pharmaceuticals, Inc. operates as a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its product candidate, CRN00808, is an oral nonpeptide somatostatin agonist for the treatment of acromegaly. The firm is also developing other oral nonpeptide somatostatin agonists for neuroendocrine tumors and hyperinsulinism, as well as an oral nonpeptide ACTH antagonist for the treatment of Cushing's disease. The company was founded by R. Scott Struthers, Yun-Fei Zhu and Stephen F. Betz in 2008 and is headquartered in San Diego, CA.

Crinetics Pharmaceuticals Inc

Crinetics Pharmaceuticals is trending due to FDA approval of their oral acromegaly drug, Palsonify, driving significant retail investor chatter. The community is focused on the potential for a short squeeze given high institutional ownership and short interest, alongside discussions about revenue projections and buyout possibilities. Broader sentiment suggests optimism regarding the drug's market potential and impact on patient care.

Eason Technology Ltd. engages in the provision of loan facilities to micro, small and medium size enterprises, and sole proprietors. It also offers microfinance lending services. The company was founded by Qi Ming Xu and Kang Kai Zeng on June 24, 2010 and is headquartered in Wuhan, China.

Eason Technology Ltd. - ADR

Eason Technology Ltd ADR

Eason Technology Ltd ADR ($DXF) is trending as traders discuss its potential for a significant price movement, pointing to its small float and past rallies. Community members are closely watching for news, particularly regarding the company's compliance filings and potential crypto-related announcements, which they believe could trigger a substantial surge. Some traders are expressing confidence, drawing comparisons to other low-float stocks that have recently experienced rapid gains.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Amazon.com Inc. (AMZN) has reportedly reached a $2.5 billion settlement with the Federal Trade Commission (FTC), resolving allegations that the company misled consumers into paying for the Prime service.&nbsp;According to a CNBC&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.cnbc.com/2025/09/25/amazon-ftc-prime-settlement.html">report</a>, the agreement comes at a time when the company and the FTC were three days into the trial in a Seattle courtroom, with the opening arguments having been made on Tuesday. The court proceedings were expected to last a month, the report added.<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="http://amazon.com">Amazon.com</a> stock inched 0.3% lower on Thursday mid-morning. On Stocktwits, retail sentiment around the stock remained in ‘extremely bullish’ territory amid ‘extremely high’ message volume levels.&nbsp;The report noted that the FTC filed the lawsuit in June 2023, alleging that Amazon used deceptive tactics to push millions of customers into Prime subscriptions and obstructed attempts to opt out.&nbsp;“Today, the Trump-Vance FTC made history and secured a record-breaking, monumental win for the millions of Americans who are tired of deceptive subscriptions that feel impossible to cancel,” said FTC Chairman Andrew N. Ferguson. “The evidence showed that Amazon used sophisticated subscription traps designed to manipulate consumers into enrolling in Prime, and then made it exceedingly hard for consumers to end their subscription.Under the terms, Amazon will pay a $1 billion civil fine to the FTC and return $1.5 billion to around 35 million consumers who were enrolled in Prime without consent or faced hurdles in canceling.&nbsp;Amazon.com stock has gained over 14% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/coreweave-deepens-openai-ties-with-6-point-5-billion-deal/chDlX75R34q">CoreWeave Deepens OpenAI Ties With A $6.5B Deal – More Details Inside</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration Amazon advertising is seen on a tv that offering promotions available on its official website to celebrate its Amazon Prime Day. (Photo Illustration by Ian Robles/Eyepix Group/LightRocket via Getty Images)

Amazon Reaches $2.5 Billion Settlement With FTC Over Prime Subscription Case: Report

According to a CNBC report, the agreement comes at a time when the company and the FTC were three days into the trial in a Seattle courtroom, with opening arguments having been made on Tuesday.

Equity

According to a CNBC report, the agreement comes at a time when the company and the FTC were three days into the trial in a Seattle courtroom, with opening arguments having been made on Tuesday.


Amazon.com (AMZN) announced on Tuesday that it has decided to close its “Amazon Fresh UK” stores, following a thorough evaluation of business operations and the substantial growth opportunities in online delivery.The company said that it would offer redeployment opportunities to as many affected employees as possible. &nbsp;“We’ve made the difficult decision to launch a consultation with employees regarding the proposed closure of our Amazon Fresh UK stores,” Amazon said.&nbsp;Retail sentiment on <a href="https://stocktwits.com/symbol/AMZN">Amazon</a> remained unchanged in the ‘bullish’ territory, with message volumes at ‘high’ levels, according to data from Stocktwits. Shares of the company were down 2.5% in early trading.The e-commerce giant said that it continues to invest and innovate to further expand online delivery of everyday essentials and fresh groceries through Amazon.co.uk, Amazon Fresh, and third-party partners. The company said it proposes closing 14 stores under the Amazon Fresh brand and converting five to the Whole Foods Market brand.Amazon said it was working to expand its online grocery selection and increase its delivery services to new areas. By early next year, the company said it plans to more than double the number of Amazon UK Prime members who have access to three or more online grocery delivery options through partners Morrisons, Iceland, Co-op, and Gopuff.In June, Amazon announced plans to invest over $50 billion in the U.K. over the next three years, creating thousands of full-time jobs, building new fulfillment centers, and driving innovation across its operations.Shares of Amazon have risen over 1% this year and gained 14% in the last 12 months.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/us-antimony-secures-245-m-defense-contract-over-five-years-report/chDhH2ZR35a">US Antimony Secures $245M Defense Contract Over Five Years: Report</a>

In this photo illustration Amazon advertising is seen on a cell phone that offering promotions available on its official website.

Amazon To Close Its ‘Amazon Fresh UK’ Stores

Amazon announced that it would offer redeployment opportunities to as many affected employees as possible following the closure of its Fresh stores.

Amazon (AMZN) is reportedly facing off against the Federal Trade Commission in a closely watched trial based on allegations that the company misled consumers into enrolling in its Prime membership program.According to a CNBC report, the trial is being held in a federal court in Seattle. The report added that the trial was expected to last approximately a month and that jury selection began on Monday, with opening arguments slated for Tuesday.The report added that the FTC filed the lawsuit in June 2023 under the Biden administration, alleging that Amazon misled tens of millions of consumers into enrolling in its Prime subscription and deliberately obstructed their efforts to cancel. The company has denied any wrongdoing.Retail sentiment around <a href="https://stocktwits.com/symbol/AMZN">Amazon</a> remained unchanged in the ‘bullish’ territory, with message volumes at ‘high’ levels, according to data from Stocktwits.CNBC noted that regulators argued that Amazon broke competition and consumer protection laws by allegedly misleading users into signing up for its Prime membership. The report said that the FTC pointed to examples like a button on its site that instructed users to complete their transaction, following which, there was no clarity given&nbsp;on whether the customers were also agreeing to join Prime for a recurring subscription.“Millions of consumers accidentally enrolled in Prime without knowledge or consent, but Amazon refused to fix this known problem, described internally by employees as an ‘unspoken cancer’ because clarity adjustments would lead to a drop in subscribers,” the agency wrote in a court filing last week, according to CNBC.Shares of Amazon have gained nearly 4% this year and jumped over 17% in the last 12 months.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/boeing-proposes-remedies-as-it-seeks-eu-green-light-for-spirit/chDhs7qR35c">Boeing Proposes Remedies As It Seeks EU Green Light For Spirit AeroSystems Deal: Report</a>

 The Amazon logo is displayed outside Amazon UK MAN8 Warehouse on January 30, 2025 in Haydock, United Kingdom. 

Amazon Faces FTC In Trial Over Alleged Prime Enrollment Strategy: Report

According to a CNBC report, the trial was expected to last approximately a month, and jury selection began on Monday, with opening arguments scheduled for Tuesday.

European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted two positive opinions for Merck’s (MRK) blockbuster cancer drug Keytruda, the company said on Friday.While one of the opinions recommends approval for a new subcutaneous route of administration and a new solution form for injection for Keytruda, the other recommends approval for the drug in treating locally advanced head and neck squamous cell carcinoma, Merck <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.merck.com/news/merck-receives-two-positive-eu-chmp-opinions-for-keytruda-pembrolizumab-for-subcutaneous-sc-administration-and-for-new-indication-for-earlier-stage-head-and-neck-cancer/">said</a>.The committee’s recommendations will now be reviewed by the European Commission. Final decisions on marketing authorization in the European Union, Iceland, Liechtenstein, and Norway are expected in the fourth quarter.Shares of the company rose marginally in Friday’s pre-market session. On Stocktwits, retail sentiment about <a href="https://stocktwits.com/symbol/MRK">MRK stock</a> stayed within the ‘bearish’ territory over the past 24 hours, while message volume fell from ‘normal’ to ‘low’ levels.If approved for under-the-skin administration by a healthcare provider, the solution form for injection of Keytruda will be marketed in the European Union as Keytruda SC, the company said. It could be administered in one minute every three weeks or in two minutes every six weeks, offering an alternative to intravenous infusion.“If approved, we believe KEYTRUDA SC has the potential to provide meaningful benefits to patients and providers in Europe because it can offer a shorter administration time compared to KEYTRUDA and the option to receive treatment in additional health care settings,” said Marjorie Green, senior vice president and head of oncology at Merck Research Laboratories. CHMP’s positive opinion applies to all Keytruda indications approved for adult patients in Europe.An application seeking approval of subcutaneous Keytruda is currently under review in the U.S. as well. The U.S. Food and Drug Administration is expected to decide on the application by September 23.The second CHMP opinion recommends approval of Keytruda as treatment of resectable locally advanced head and neck squamous cell carcinoma (LA-HNSCC). Head and neck cancer describes several different tumors that develop in or around the throat, larynx, nose, sinuses, and mouth. It is estimated that there were more than 947,200 new cases of head and neck cancer diagnosed globally and more than 482,400 deaths from the disease in 2022, Merck said.Keytruda is Merck’s best-selling drug. In the second quarter, the company reported sales of $8 billion from Keytruda, representing a 9% year-over-year growth.MRK stock is down 18% this year and approximately 30% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/dow-futures-edge-lower-ahead-of-trump-xi-call/chD3b7SR3Rq">Dow Futures Edge Lower As Investors Watch Out For Trump-Xi Call: FDX, UPS, LEN, INTC Among Stocks To Watch</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Medicine pill is seen with Merck logo displayed on a screen in the background in this illustration photo taken in Poland on November 5, 2021. (Photo by Jakub Porzycki/NurPhoto via Getty Images)

Merck Says EMA Committee Adopted Two Positive Opinions For Expanding Use Of Cancer Drug Keytruda

While one of the opinions recommends approval for a new subcutaneous route of administration for Keytruda, the other recommends approval for the drug in treating locally advanced head and neck squamous cell carcinoma, according to Merck. 

Alphabet’s (GOOG, GOOGL) Google said in a blog post that it was rolling out its artificial intelligence assistant Gemini on its web browser Chrome for Mac and Windows desktop users in the U.S. starting on Thursday.&nbsp;&nbsp;Google stated that it would be made available to businesses in the coming weeks via Google Workspace with enterprise-grade data protections and controls.The company added that it was also bringing Gemini in Chrome to mobile users in the U.S. It noted that a user can activate Gemini when using Chrome on Android and other apps by holding the power button. Google said starting soon, even on iOS, Gemini in Chrome will be built into the app.Retail sentiment on <a href="https://stocktwits.com/symbol/GOOGL">Alphabet</a> remained unchanged in the ‘neutral’ territory, with message volumes at ‘normal’ levels, according to data from Stocktwits. Shares of Alphabet were up nearly 1% during midday trading.Google noted that this would help users ask Gemini to clarify complex information on any webpage (or webpages) they are reading. In the coming months, it will introduce agent-based capabilities to Gemini in Chrome. This feature would enable Gemini in Chrome to handle tedious tasks that consume a lot of time, such as booking a haircut or ordering weekly groceries.&nbsp;Google added that it would soon let users use Gemini in Chrome to recall and find a website they had earlier visited by using prompts such as “what was the website that I saw the walnut desk on last week?” or “what was that blog I read on back to school shopping?”Shares of Alphabet have jumped nearly 33% this year and gained about 55% in the last 12 months.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/meta-chief-product-officer-has-an-interesting-take-on-smart-glasses/chD2cZFR3bV">Meta’s Chief Product Officer Has An Interesting Take On Smart Glasses – More Details Inside</a>

The Gemini app on a smartphone screen, as an index finger approaches the app's icon. (Photo by Matthias Balk/picture alliance via Getty Images)

Google Brings Gemini To Chrome For Users In The US

Google announced that Gemini in Chrome will be made available to businesses in the coming weeks via Google Workspace, offering enterprise-grade data protections and controls.

Meta Platforms (META) Chief Product Officer Chris Cox reportedly said that smart glasses will be the future of computing devices.According to a CNBC report on Thursday, Cox said in an interview, “We talk to them, we will see with them, we will use gestures the same way we interact with each other to interact with our computers.”“The interfaces will get more natural, and so we certainly believe that the next really important wearable technology is going to be a pair of glasses,” Cox told CNBC.Retail sentiment about the stock improved to ‘extremely bullish’ from ‘bullish’ territory a day ago, with chatter at ‘high’ levels, according to data from Stocktwits. Shares of the company were up nearly 1% during midday trading.On Wednesday, Mark Zuckerberg unveiled the Meta Ray-Ban Display AI glasses at the Meta Connect 2025 conference. Zuckerberg noted that these were the advanced AI glasses to date, featuring a full-color, high-resolution display. The company said that each pair comes with its own Meta Neural Band, an EMG wristband that translates the signals created by human muscles, such as subtle finger movements, into commands for the glasses.Meta said that the price of the glasses starts at $799, which includes both the glasses and the Meta Neural Band. Meta Ray-Ban Display will hit shelves September 30 at limited brick-and-mortar retailers in the U.S., the company said. These retailers would be Best Buy, Sunglass Hut, and Ray-Ban Stores.Cox, on Thursday, told CNBC that users will be able to record videos and also send messages via voice or physically using handwriting gestures on their knee.Shares of <a href="https://stocktwits.com/symbol/META">Meta</a> have gained nearly 34% this year and increased by 40% over the last 12 months.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/darden-flags-q2-profit-slowdown-amid-surging-beef-costs/chD2bM4R3b1">Darden Flags Q2 Profit Slowdown Amid Surging Beef Costs, CFO Says Price Spike Is Unsustainable</a>

The Meta Ray-Ban smart glasses are exhibited in Matte Black and Dusty Blue colors during the Mobile World Congress 2025 in Barcelona, Spain, on March 5, 2025. 

Meta’s Chief Product Officer Has An Interesting Take On Smart Glasses – More Details Inside

In an interview with CNBC, Cox stated that humans communicate with them, they see with them, and use gestures in the same way they interact with each other to interact with computers.

General Motors (GM) is reportedly in preliminary talks to renew its joint venture with China’s SAIC Motor Corp.Bloomberg <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-09-17/gm-is-in-talks-to-extend-china-venture-with-demand-recovering">reported</a> on Wednesday, citing unnamed people familiar with the matter, that the two automakers are exploring elements of a potential agreement, including which vehicle models and plants would be involved if a deal is reached.The report noted that the talks are in an early stage and the final terms have not been determined yet. GM and SAIC’s partnership dates back 30 years. <a href="https://stocktwits.com/symbol/GM">GM stock</a> rose 1% at the time of writing.&nbsp;On Stocktwits, retail sentiment around GM stock fell from ‘neutral’ to ‘bearish’ territory over the past 24 hours, while message volume stayed at ‘normal’ levels.<figure class="image"><img style="aspect-ratio:620/64;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_17_at_1_13_01_PM_png_15b2712564.webp" alt="GM's Sentiment Meter and Message Volume as of 1:13 p.m. ET on Sept. 17, 2025 | Source: Stocktwits" width="620" height="64"><figcaption>GM's Sentiment Meter and Message Volume as of 1:13 p.m. ET on Sept. 17, 2025 | Source: Stocktwits</figcaption></figure>In July, GM announced that the company and its joint ventures in China had posted the largest quarterly sales surge in four years during the second quarter (Q2). Deliveries exceeded 447,000 units, marking GM’s second consecutive quarter of year-over-year sales growth in China with a 20% increase. Cumulative sales in the first half of 2025 exceeded 890,000 units, up 9.4% from a year earlier.“We remain committed to driving profitable growth for China business by focusing on strong execution, business agility and customer choices,” Steve Hill, president of GM China, said in July.However, domestic players, including EV maker BYD, have been taking greater control of the Chinese auto market. Companies have also been cutting prices in a bid to retain market share. In 2024, GM incurred equity loss of $4.4 billion from its China JVs. In addition to a venture with SAIC, GM has a second venture with SAIC and Wuling Motors Holdings.GM stock is up by 10% this year and about 24% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/j-and-j-investigational-plaque-psoriasis-drug-outperforms-bristol-myers-squibbs-sotyktu-in-study/chDGHQHRd68">J&amp;J’s Investigational Plaque Psoriasis Drug Outperforms Bristol Myers’ Sotyktu In Study</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The hand of a statue appears in front of a view of office highrises of US car giant General Motors (GM) in Detroit, USA, 13 January 2013. Photo: Uli Deck | usage worldwide (Photo by Uli Deck/picture alliance via Getty Images)  

GM In Talks To Renew JV With China’s SAIC: Report 

Bloomberg reported on Wednesday, citing unnamed people familiar with the matter, that the two automakers are exploring elements of a potential agreement, including which vehicle models and plants would be involved if a deal is reached. 

Amazon.com (AMZN) has reportedly rejigged its artificial intelligence assistant for online merchants as part of an effort to support sellers facing a challenging holiday season, which is being shaped by ongoing US-China trade tensions.According to a Bloomberg News report, the Seller Assistant by Amazon is designed to forecast demand and assist in inventory management. It does so by informing sellers of the quantity of products that should be ordered, the likely timing for offering discounts during the holiday season to boost sales, and when to retrieve inventory from Amazon’s warehouse to avoid storage fees.The report noted that the Seller Assistant’s first version was trained to respond to merchants' queries, and the reworked design would help them with selling suggestions.Retail sentiment on <a href="https://stocktwits.com/symbol/AMZN">Amazon</a> was in the ‘bullish’ territory compared to the ‘extremely bullish’ territory a day ago, with message volumes at ‘high’ levels, according to data from Stocktwits. Shares of the company were down 1% in early trading.&nbsp;&nbsp;According to the Bloomberg report, Amazon Vice President Dharmesh Mehta said that the model was trained on 25 years of shopping behavior and includes supply-chain disruptions of the pandemic, as well as the decades-high inflation and soaring interest rate periods.Mehta noted that the goal was to assist merchants “navigate volatility.” “It’s going to save sellers money and it’s going to save them time,” he told Bloomberg.The report also noted that other e-commerce consultants and software companies provide similar assistance, but Amazon offers its US merchants the Seller Assistant for free and plans to eventually deploy it globally.Shares of Amazon have gained 5.5% this year and have jumped over 24% in the last 12 months.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/mcdonalds-stock-edges-higher-after-citigroup-boosts-price-target/chDGYvWRd6a">McDonald’s Stock Edges Higher After Citigroup Boosts Price Target</a>

Amazon Rejigs AI Assistant For Online Sellers: Report

According to a Bloomberg News report, the Seller Assistant by Amazon is designed to forecast demand and assist in inventory management.

The Amazon Prime Day logo appears on the screen of a smartphone. (Photo by Jaque Silva/NurPhoto via Getty Images)

Amazon Stock Received A Price Target Hike From Truist – Here’s Why

Truist stated that Amazon's North American revenue is tracking approximately $1 billion ahead of the consensus estimate of $105 billion, according to its card data through September 6.

Shares of Hims &amp; Hers Health (HIMS) slumped 7% on Tuesday after the U.S. Food and Drug Administration (FDA) sent a letter to the company CEO regarding the sale of compounded drug products.In the letter <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/hims-hers-health-inc-dba-hers-09092025">dated</a> September 9, the agency alleged that the company’s claims concerning compounded Semaglutide products, used for weight loss, are “false or misleading.” The FDA also noted that this is a violation of certain sections of the Federal Food, Drug, and Cosmetic Act.The FDA pointed out that compounded drug products are not approved by it. “Your claims imply that your products are the same as an FDA-approved product when they are not,” the letter said, while urging the company to take immediate action to address violations. A failure to adequately address any violation may result in legal action without further notice, it added.The FDA further alleged that these compounded products are misbranded and noted that the introduction of misbranded products into interstate commerce is prohibited. While the letter referred to two claims made on compounded Semaglutide products made on Hims’ website, it does not represent an exhaustive list of misbranding violations, the agency said.The FDA has given CEO Andrew Dudum 15 working days from the receipt of the letter to provide a written response describing the steps taken to address violations or to provide reasoning and supporting information if he believes the company is not in violation.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/HIMS">HIMS stock</a> jumped from ‘bullish’ to 'extremely bullish' territory over the past 24 hours, while message volume stayed at ‘high’ levels.In June, Novo Nordisk (NVO) <a href="https://stocktwits.com/news-articles/markets/equity/hims-stock-plunges-after-novo-nordisk-ends-wegovy-partnership/chm55y3RR5v">said</a> that it is halting collaboration with Hims &amp; Hers for the sale of its blockbuster weight loss drug Wegovy, the key ingredient of which is Semaglutide. Novo said that Hims &amp; Hers failed to adhere to the law, which prohibits mass sales of compounded drugs. It further alleged that the telehealth operator is promoting and selling illegitimate, knockoff versions of Wegovy and has hence decided to halt the collaboration entered into in late April.Dudum, however, subsequently <a href="https://stocktwits.com/news-articles/markets/equity/hims-and-hers-hits-back-at-novo-nordisk-after-collaboration-end/chm5fs2RRd4">alleged</a> that Novo’s management is “misleading the public.” The CEO stated in a post on X that the pharmaceutical company’s commercial team has been pressuring the company to control clinical standards and steer patients toward Wegovy, regardless of whether it is clinically the best option for patients.HIMS stock has more than doubled its value this year and tripled over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/eli-lilly-to-set-up-5-billion-facility-in-virginia/chwymFcRdzj">Eli Lilly To Set Up $5B Facility In Virginia – More Details Inside</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the logo of Hims & Hers Health, Inc. is displayed on a smartphone screen on May 04, 2025, in Chongqing, China. (Photo illustration by Cheng Xin/Getty Images)

Hims & Hers Stock Draws Investor Attention After Tumbling 7% – Here’s What Happened

In a letter dated September 9, the FDA alleged that the company’s claims concerning compounded Semaglutide products are “false or misleading.”

Vanguard Group, Inc. - Vanguard U.S. Multifactor ETF

$5,000

$6,000

$7,000

$8,000

What price will Ethereum hit in 2025? 
 
*Powered by Polymarket

Current Price	$128.40
Prev Close	$126.76
Open	$125.53
Dividend Yield	N/A
50-Day Moving Average	$131.95
Beta	N/A
Avg. Volume	12,979.43
PE Ratio	N/A

52-Week High	$142.19
52-Week Low	$117.60
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

VFMF
Vanguard Group, Inc. - Vanguard U.S. Multifactor ETF

Feed

News

Sentiment

Fundamentals

Info

Latest VFMF News

VFMF Vanguard Group, Inc. - Vanguard U.S. Multifactor ETF